Works by Dimopoulos, Meletios-Athanasios

Results: 187
    1

    Re-evaluation of Mayo 2004 and revised Mayo 2012 staging in patients with AL amyloidosis in the era of new therapies.

    Published in:
    2025
    By:
    • Theodorakakou, Foteini;
    • Fotiou, Despina;
    • Spiliopoulou, Vasiliki;
    • Migkou, Magdalini;
    • Malandrakis, Panagiotis;
    • Ntanasis-Stathopoulos, Ioannis;
    • Roussou, Maria;
    • Kanellias, Nikolaos;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Solia, Eirini;
    • Papanikolaou, Asimina;
    • Gakiopoulou, Charikleia;
    • Courraud, Julie;
    • Nikolaou, Panagiota-Efstathia;
    • Giannouli, Stavroula;
    • Gavriatopoulou, Maria;
    • Terpos, Evangelos;
    • Dimopoulos, Meletios-Athanasios;
    • Kastritis, Efstathios
    Publication type:
    Letter to the Editor
    2

    Clinical perspectives of BET inhibition in ovarian cancer.

    Published in:
    Cellular Oncology (2211-3428), 2021, v. 44, n. 2, p. 237, doi. 10.1007/s13402-020-00578-6
    By:
    • Andrikopoulou, Angeliki;
    • Liontos, Michalis;
    • Koutsoukos, Konstantinos;
    • Dimopoulos, Meletios-Athanasios;
    • Zagouri, Flora
    Publication type:
    Article
    3

    The Prognostic Role of BRD4 Expression in High-Grade Serous Ovarian Cancer.

    Published in:
    Cancers, 2024, v. 16, n. 11, p. 1962, doi. 10.3390/cancers16111962
    By:
    • Andrikopoulou, Angeliki;
    • Bletsa, Garyfalia;
    • Rouvalis, Angeliki;
    • Tsakogiannis, Dimitris;
    • Kaparelou, Maria;
    • Papatheodoridi, Alkistis;
    • Haidopoulos, Dimitrios;
    • Liontos, Michalis;
    • Dimopoulos, Meletios-Athanasios;
    • Zagouri, Flora
    Publication type:
    Article
    4
    5

    Optimal Time Interval between Neoadjuvant Platinum-Based Chemotherapy and Interval Debulking Surgery in High-Grade Serous Ovarian Cancer.

    Published in:
    Cancers, 2023, v. 15, n. 13, p. 3519, doi. 10.3390/cancers15133519
    By:
    • Andrikopoulou, Angeliki;
    • Theofanakis, Charalampos;
    • Markellos, Christos;
    • Kaparelou, Maria;
    • Koutsoukos, Konstantinos;
    • Apostolidou, Kleoniki;
    • Thomakos, Nikolaos;
    • Haidopoulos, Dimitrios;
    • Rodolakis, Alexandros;
    • Dimopoulos, Meletios-Athanasios;
    • Zagouri, Flora;
    • Liontos, Michalis
    Publication type:
    Article
    6
    7
    8

    Low Spike Antibody Levels and Impaired BA.4/5 Neutralization in Patients with Multiple Myeloma or Waldenstrom's Macroglobulinemia after BNT162b2 Booster Vaccination.

    Published in:
    Cancers, 2022, v. 14, n. 23, p. 5816, doi. 10.3390/cancers14235816
    By:
    • Rosati, Margherita;
    • Terpos, Evangelos;
    • Bear, Jenifer;
    • Burns, Robert;
    • Devasundaram, Santhi;
    • Ntanasis-Stathopoulos, Ioannis;
    • Gavriatopoulou, Maria;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios-Athanasios;
    • Pavlakis, George N.;
    • Felber, Barbara K.
    Publication type:
    Article
    9

    SARS-CoV-2 Neutralizing Antibodies Kinetics Postvaccination in Cancer Patients under Treatment with Immune Checkpoint Inhibition.

    Published in:
    Cancers, 2022, v. 14, n. 11, p. 2796, doi. 10.3390/cancers14112796
    By:
    • Terpos, Evangelos;
    • Liontos, Michalis;
    • Fiste, Oraianthi;
    • Zagouri, Flora;
    • Briasoulis, Alexandros;
    • Sklirou, Aimilia D.;
    • Markellos, Christos;
    • Skafida, Efthymia;
    • Papatheodoridi, Alkistis;
    • Andrikopoulou, Angeliki;
    • Koutsoukos, Konstantinos;
    • Kaparelou, Maria;
    • Iconomidou, Vassiliki A.;
    • Trougakos, Ioannis P.;
    • Dimopoulos, Meletios-Athanasios
    Publication type:
    Article
    10

    Daratumumab Improves Bone Turnover in Relapsed/Refractory Multiple Myeloma; Phase 2 Study "REBUILD".

    Published in:
    Cancers, 2022, v. 14, n. 11, p. 2768, doi. 10.3390/cancers14112768
    By:
    • Terpos, Evangelos;
    • Ntanasis-Stathopoulos, Ioannis;
    • Kastritis, Efstathios;
    • Hatjiharissi, Evdoxia;
    • Katodritou, Eirini;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Verrou, Evgenia;
    • Gavriatopoulou, Maria;
    • Leonidakis, Alexandros;
    • Manousou, Kyriaki;
    • Delimpasi, Sosana;
    • Malandrakis, Panagiotis;
    • Kyrtsonis, Marie-Christine;
    • Papaioannou, Maria;
    • Symeonidis, Argiris;
    • Dimopoulos, Meletios-Athanasios
    Publication type:
    Article
    11
    12
    13

    Aberrant Plasma Cell Contamination of Peripheral Blood Stem Cell Autografts, Assessed by Next-Generation Flow Cytometry, Is a Negative Predictor for Deep Response Post Autologous Transplantation in Multiple Myeloma; A Prospective Study in 199 Patients.

    Published in:
    Cancers, 2021, v. 13, n. 16, p. 4047, doi. 10.3390/cancers13164047
    By:
    • Kostopoulos, Ioannis V.;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Rousakis, Pantelis;
    • Ntanasis-Stathopoulos, Ioannis;
    • Panteli, Chrysanthi;
    • Orologas-Stavrou, Nikolaos;
    • Kanellias, Nikolaos;
    • Malandrakis, Panagiotis;
    • Liacos, Christine-Ivy;
    • Papaioannou, Nikos E.;
    • Papanota, Aristea-Maria;
    • Migkou, Magdalini;
    • Fotiou, Despina;
    • Gavriatopoulou, Maria;
    • Angelis, Nikolaos V.;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios-Athanasios;
    • Tsitsilonis, Ourania E.;
    • Terpos, Evangelos
    Publication type:
    Article
    14

    A Molecular Signature of Circulating MicroRNA Can Predict Osteolytic Bone Disease in Multiple Myeloma.

    Published in:
    Cancers, 2021, v. 13, n. 15, p. 3877, doi. 10.3390/cancers13153877
    By:
    • Papanota, Aristea-Maria;
    • Tsiakanikas, Panagiotis;
    • Kontos, Christos K.;
    • Malandrakis, Panagiotis;
    • Liacos, Christine-Ivy;
    • Ntanasis-Stathopoulos, Ioannis;
    • Kanellias, Nikolaos;
    • Gavriatopoulou, Maria;
    • Kastritis, Efstathios;
    • Avgeris, Margaritis;
    • Dimopoulos, Meletios-Athanasios;
    • Scorilas, Andreas;
    • Terpos, Evangelos
    Publication type:
    Article
    15

    Continuing Cancer Therapy through the Pandemic While Protecting Our Patients: Results of the Implementation of Preventive Strategies in a Referral Oncology Unit.

    Published in:
    Cancers, 2021, v. 13, n. 4, p. 763, doi. 10.3390/cancers13040763
    By:
    • Liontos, Michalis;
    • Kastritis, Efstathios;
    • Markellos, Christos;
    • Migkou, Magdalini;
    • Eleftherakis-Papaiakovou, Evangelos;
    • Koutsoukos, Konstantinos;
    • Gavriatopoulou, Maria;
    • Zagouri, Flora;
    • Psaltopoulou, Theodora;
    • Terpos, Evangelos;
    • Dimopoulos, Meletios-Athanasios;
    • D'Orazi, Gabriella;
    • Cirone, Mara
    Publication type:
    Article
    16
    17
    18

    Deep Phenotyping Reveals Distinct Immune Signatures Correlating with Prognostication, Treatment Responses, and MRD Status in Multiple Myeloma.

    Published in:
    Cancers, 2020, v. 12, n. 11, p. 3245, doi. 10.3390/cancers12113245
    By:
    • Papadimitriou, Konstantinos;
    • Tsakirakis, Nikolaos;
    • Malandrakis, Panagiotis;
    • Vitsos, Panagiotis;
    • Metousis, Andreas;
    • Orologas-Stavrou, Nikolaos;
    • Ntanasis-Stathopoulos, Ioannis;
    • Kanellias, Nikolaos;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Pothos, Panagiotis;
    • Fotiou, Despina;
    • Gavriatopoulou, Maria;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios-Athanasios;
    • Terpos, Evangelos;
    • Tsitsilonis, Ourania E.;
    • Kostopoulos, Ioannis V.
    Publication type:
    Article
    19

    Antitumor Reactive T-Cell Responses Are Enhanced In Vivo by DAMP Prothymosin Alpha and Its C-Terminal Decapeptide.

    Published in:
    Cancers, 2019, v. 11, n. 11, p. 1764, doi. 10.3390/cancers11111764
    By:
    • Birmpilis, Anastasios I.;
    • Karachaliou, Chrysoula-Evangelia;
    • Samara, Pinelopi;
    • Ioannou, Kyriaki;
    • Selemenakis, Platon;
    • Kostopoulos, Ioannis V.;
    • Kavrochorianou, Nadia;
    • Kalbacher, Hubert;
    • Livaniou, Evangelia;
    • Haralambous, Sylva;
    • Kotsinas, Athanasios;
    • Farzaneh, Farzin;
    • Trougakos, Ioannis P.;
    • Voelter, Wolfgang;
    • Dimopoulos, Meletios-Athanasios;
    • Bamias, Aristotelis;
    • Tsitsilonis, Ourania
    Publication type:
    Article
    20

    Imaging of cardiac amyloidosis by <sup>99m</sup>Tc-PYP scintigraphy.

    Published in:
    Hellenic Journal of Nuclear Medicine, 2015, v. 18, p. 42
    By:
    • Papantoniou, Vasileios;
    • Valsamaki, Pipitsa;
    • Kastritis, Stathis;
    • Tsiouris, Spyridon;
    • Delichas, Zisis;
    • Papantoniou, Yiannis;
    • Tsiouma, Maria;
    • Athanasoulis, Theodoros;
    • Fotopoulos, Andreas;
    • Dimopoulos, Meletios Athanasios
    Publication type:
    Article
    21

    miRNA-seq and clinical evaluation in multiple myeloma: miR-181a overexpression predicts short-term disease progression and poor post-treatment outcome.

    Published in:
    2022
    By:
    • Papadimitriou, Maria-Alexandra;
    • Papanota, Aristea-Maria;
    • Adamopoulos, Panagiotis G.;
    • Pilala, Katerina-Marina;
    • Liacos, Christine-Ivy;
    • Malandrakis, Panagiotis;
    • Mavrianou-Koutsoukou, Nefeli;
    • Patseas, Dimitrios;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Gavriatopoulou, Maria;
    • Kastritis, Efstathios;
    • Avgeris, Margaritis;
    • Dimopoulos, Meletios-Athanasios;
    • Terpos, Evangelos;
    • Scorilas, Andreas
    Publication type:
    journal article
    22
    23
    24

    Control of SARS-CoV-2 infection after Spike DNA or Spike DNA+Protein co-immunization in rhesus macaques.

    Published in:
    PLoS Pathogens, 2021, v. 17, n. 9, p. 1, doi. 10.1371/journal.ppat.1009701
    By:
    • Rosati, Margherita;
    • Agarwal, Mahesh;
    • Hu, Xintao;
    • Devasundaram, Santhi;
    • Stellas, Dimitris;
    • Chowdhury, Bhabadeb;
    • Bear, Jenifer;
    • Burns, Robert;
    • Donohue, Duncan;
    • Pessaint, Laurent;
    • Andersen, Hanne;
    • Lewis, Mark G.;
    • Terpos, Evangelos;
    • Dimopoulos, Meletios Athanasios;
    • Wlodawer, Alexander;
    • Mullins, James I.;
    • Venzon, David J.;
    • Pavlakis, George N.;
    • Felber, Barbara K.
    Publication type:
    Article
    25
    26

    The Cytogenetic Profile of Primary and Secondary Plasma Cell Leukemia: Etiopathogenetic Perspectives, Prognostic Impact and Clinical Relevance to Newly Diagnosed Multiple Myeloma with Differential Circulating Clonal Plasma Cells.

    Published in:
    Biomedicines, 2022, v. 10, n. 2, p. 209, doi. 10.3390/biomedicines10020209
    By:
    • Papadhimitriou, Stefanos I.;
    • Terpos, Evangelos;
    • Liapis, Konstantinos;
    • Pavlidis, Dimitrios;
    • Marinakis, Theodoros;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios-Athanasios;
    • Tsitsilonis, Ourania E.;
    • Kostopoulos, Ioannis V.
    Publication type:
    Article
    27

    tRNA Derivatives in Multiple Myeloma: Investigation of the Potential Value of a tRNA-Derived Molecular Signature.

    Published in:
    Biomedicines, 2021, v. 9, n. 12, p. 1811, doi. 10.3390/biomedicines9121811
    By:
    • Karousi, Paraskevi;
    • Papanota, Aristea-Maria;
    • Artemaki, Pinelopi I.;
    • Liacos, Christine-Ivy;
    • Patseas, Dimitrios;
    • Mavrianou-Koutsoukou, Nefeli;
    • Liosi, Aikaterini-Anna;
    • Kalioraki, Maria-Anna;
    • Ntanasis-Stathopoulos, Ioannis;
    • Gavriatopoulou, Maria;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios-Athanasios;
    • Scorilas, Andreas;
    • Terpos, Evangelos;
    • Kontos, Christos K.
    Publication type:
    Article
    28
    29

    Correction: Isatuximab, carfilzomib, and dexamethasone in patients with relapsed multiple myeloma: updated results from IKEMA, a randomized Phase 3 study.

    Published in:
    2023
    By:
    • Martin, Thomas;
    • Dimopoulos, Meletios-Athanasios;
    • Mikhael, Joseph;
    • Yong, Kwee;
    • Capra, Marcelo;
    • Facon, Thierry;
    • Hajek, Roman;
    • Špička, Ivan;
    • Baker, Ross;
    • Kim, Kihyun;
    • Martinez, Gracia;
    • Min, Chang-Ki;
    • Pour, Ludek;
    • Leleu, Xavier;
    • Oriol, Albert;
    • Koh, Youngil;
    • Suzuki, Kenshi;
    • Casca, France;
    • Macé, Sandrine;
    • Risse, Marie-Laure
    Publication type:
    Correction Notice
    30

    Isatuximab, carfilzomib, and dexamethasone in patients with relapsed multiple myeloma: updated results from IKEMA, a randomized Phase 3 study.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00797-8
    By:
    • Martin, Thomas;
    • Dimopoulos, Meletios-Athanasios;
    • Mikhael, Joseph;
    • Yong, Kwee;
    • Capra, Marcelo;
    • Facon, Thierry;
    • Hajek, Roman;
    • Špička, Ivan;
    • Baker, Ross;
    • Kim, Kihyun;
    • Martinez, Gracia;
    • Min, Chang-Ki;
    • Pour, Ludek;
    • Leleu, Xavier;
    • Oriol, Albert;
    • Koh, Youngil;
    • Suzuki, Kenshi;
    • Casca, France;
    • Macé, Sandrine;
    • Risse, Marie-Laure
    Publication type:
    Article
    31

    Isatuximab, carfilzomib, and dexamethasone in patients with relapsed multiple myeloma: updated results from IKEMA, a randomized Phase 3 study.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00797-8
    By:
    • Martin, Thomas;
    • Dimopoulos, Meletios-Athanasios;
    • Mikhael, Joseph;
    • Yong, Kwee;
    • Capra, Marcelo;
    • Facon, Thierry;
    • Hajek, Roman;
    • Špička, Ivan;
    • Baker, Ross;
    • Kim, Kihyun;
    • Martinez, Gracia;
    • Min, Chang-Ki;
    • Pour, Ludek;
    • Leleu, Xavier;
    • Oriol, Albert;
    • Koh, Youngil;
    • Suzuki, Kenshi;
    • Casca, France;
    • Macé, Sandrine;
    • Risse, Marie-Laure
    Publication type:
    Article
    32

    Isatuximab, carfilzomib, and dexamethasone in patients with relapsed multiple myeloma: updated results from IKEMA, a randomized Phase 3 study.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00797-8
    By:
    • Martin, Thomas;
    • Dimopoulos, Meletios-Athanasios;
    • Mikhael, Joseph;
    • Yong, Kwee;
    • Capra, Marcelo;
    • Facon, Thierry;
    • Hajek, Roman;
    • Špička, Ivan;
    • Baker, Ross;
    • Kim, Kihyun;
    • Martinez, Gracia;
    • Min, Chang-Ki;
    • Pour, Ludek;
    • Leleu, Xavier;
    • Oriol, Albert;
    • Koh, Youngil;
    • Suzuki, Kenshi;
    • Casca, France;
    • Macé, Sandrine;
    • Risse, Marie-Laure
    Publication type:
    Article
    33
    34

    Reduced Antibodies and Innate Cytokine Changes in SARS-CoV-2 BNT162b2 mRNA Vaccinated Transplant Patients With Hematological Malignancies.

    Published in:
    Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.899972
    By:
    • Bergamaschi, Cristina;
    • Pagoni, Maria;
    • Rosati, Margherita;
    • Angel, Matthew;
    • Tzannou, Ifigeneia;
    • Vlachou, Margarita;
    • Darmani, Ismini;
    • Ullah, Amirah;
    • Bear, Jenifer;
    • Devasundaram, Santhi;
    • Burns, Robert;
    • Baltadakis, Ioannis;
    • Gigantes, Stavros;
    • Dimopoulos, Meletios-Athanasios;
    • Pavlakis, George N.;
    • Terpos, Evangelos;
    • Felber, Barbara K.
    Publication type:
    Article
    35
    36

    Impact of daratumumab on stem cell mobilization and collection, engraftment and early post-transplant complications among multiple myeloma patients undergoing autologous stem cell transplantation.

    Published in:
    Leukemia & Lymphoma, 2023, v. 64, n. 13, p. 2140, doi. 10.1080/10428194.2023.2253479
    By:
    • Eleutherakis Papaiakovou, Evangelos;
    • Terpos, Evangelos;
    • Kanellias, Nikolaos;
    • Migkou, Magdalini;
    • Gavriatopoulou, Maria;
    • Ntanasis-Stathopoulos, Ioannis;
    • Fotiou, Despoina;
    • Malandrakis, Panagiotis;
    • Theodorakakou, Foteini;
    • Spiliopoulou, Vasiliki;
    • Kostopoulos, Ioannis V.;
    • Tsitsiloni, Ourania;
    • Tsirigotis, Panagiotis;
    • Dimopoulos, Meletios-Athanasios;
    • Kastritis, Efstathios
    Publication type:
    Article
    37

    Patterns of target organ amyloid deposition in patients with AL amyloidosis; role for diagnosis and prognosis.

    Published in:
    Leukemia & Lymphoma, 2023, v. 64, n. 6, p. 1212, doi. 10.1080/10428194.2023.2197537
    By:
    • Fotiou, Despina;
    • Theodorakakou, Foteini;
    • Malandrakis, Panagiotis;
    • Ntanasis-Stathopoulos, Ioannis;
    • Gavriatopoulou, Maria;
    • Kanellias, Nikolaos;
    • Migkou, Magdalini;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Papanikolaou, Asimina;
    • Gakiopoulou, Charikleia;
    • Terpos, Evangelos;
    • Dimopoulos, Meletios Athanasios;
    • Kastritis, Efstathios
    Publication type:
    Article
    38
    39
    40

    Vulnerability variables among octogenerian myeloma patients: a single-center analysis of 110 patients.

    Published in:
    Leukemia & Lymphoma, 2019, v. 60, n. 3, p. 619, doi. 10.1080/10428194.2018.1509323
    By:
    • Gavriatopoulou, Maria;
    • Fotiou, Despina;
    • Koloventzou, Ursula;
    • Roussou, Maria;
    • Migkou, Magdalini;
    • Ntanasis-Stathopoulos, Ioannis;
    • Kanellias, Nikolaos;
    • Ziogas, Dimitrios C.;
    • Panagiotidis, Ioannis;
    • Gika, Dimitra;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Terpos, Evangelos;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios Athanasios
    Publication type:
    Article
    41
    42
    43
    44
    45
    46

    The combination of bevacizumab/temsirolimus after first-line anti-VEGF therapy in advanced renal-cell carcinoma: a clinical and biomarker study.

    Published in:
    International Journal of Clinical Oncology, 2019, v. 24, n. 4, p. 411, doi. 10.1007/s10147-018-1361-9
    By:
    • Bamias, Aristotelis;
    • Karavasilis, Vasilios;
    • Gavalas, Nikolaos;
    • Tzannis, Kimon;
    • Samantas, Epaminontas;
    • Aravantinos, Gerasimos;
    • Koutras, Angelos;
    • Gkerzelis, Ioannis;
    • Kostouros, Euthymios;
    • Koutsoukos, Konstantinos;
    • Zagouri, Flora;
    • Fountzilas, George;
    • Dimopoulos, Meletios-Athanasios
    Publication type:
    Article
    47

    Low circulating tumor cell levels correlate with favorable outcomes and distinct biological features in multiple myeloma.

    Published in:
    American Journal of Hematology, 2024, v. 99, n. 10, p. 1887, doi. 10.1002/ajh.27414
    By:
    • Kostopoulos, Ioannis V.;
    • Ntanasis‐Stathopoulos, Ioannis;
    • Rousakis, Pantelis;
    • Malandrakis, Panagiotis;
    • Panteli, Chrysanthi;
    • Eleutherakis‐Papaiakovou, Evangelos;
    • Angelis, Nikolaos;
    • Spiliopoulou, Vasiliki;
    • Syrigou, Rodanthi‐Eleni;
    • Bakouros, Panagiotis;
    • Dimitrakopoulou, Georgia;
    • Fotiou, Despina;
    • Migkou, Magdalini;
    • Kanellias, Nikolaos;
    • Paschalidis, Nikolaos;
    • Gavriatopoulou, Maria;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios‐Athanasios;
    • Tsitsilonis, Ourania E.;
    • Terpos, Evangelos
    Publication type:
    Article
    48
    49

    Belantamab mafodotin induces immunogenic cell death within 24 h post‐administration in newly diagnosed multiple myeloma patients.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 3, p. E65, doi. 10.1002/ajh.26823
    By:
    • Kostopoulos, Ioannis V.;
    • Kakalis, Antonis;
    • Birmpilis, Anastasios;
    • Angelis, Nikolaos;
    • Orologas‐Stavrou, Nikolaos;
    • Rousakis, Pantelis;
    • Panteli, Chrysanthi;
    • Gavriatopoulou, Maria;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios‐Athanasios;
    • Tsitsilonis, Ourania;
    • Terpos, Evangelos
    Publication type:
    Article
    50